ESSA Pharma to Participate in Two Upcoming Investor Conferences

Rhea-AI Summary

ESSA Pharma (NASDAQ: EPIX) announced its participation in two investor conferences, aimed at discussing its innovative prostate cancer therapies. The events include:

• Jefferies London Healthcare Conference: November 17, 2022, at 3:15 p.m. GMT.
• Piper Sandler 34th Annual Healthcare Conference: November 29, 2022, at 4:30 p.m. ET.

David R. Parkinson, CEO, along with other executives, will host one-on-one meetings. A live webcast of the Jefferies chat will be available on ESSA's website, archived for 90 days.

SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, Nov. 10, 2022 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be participating in two upcoming investor conferences.

David. R. Parkinson, President and Chief Executive Officer of ESSA Pharma, will participate in and host one-on-one meetings. Peter Virsik, ESSA's Chief Operating Officer, and David S. Wood, ESSA's Chief Financial Officer, will also be participating in one-on-one meetings

Presentation Details

Event: Jefferies London Healthcare Conference 
Format: Fireside Chat 
Date: Thursday, November 17, 2022 
Time: 3:15 p.m. GMT / 10:15 a.m. ET

Event: Piper Sandler 34^th Annual Healthcare Conference 
Format: Fireside Chat 
Date: Tuesday, November 29, 2022 
Time: 4:30 p.m. ET

A live webcast of the Jefferies fireside chat can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the event, the webcast will be archived on the ESSA website for 90 days.

About ESSA Pharma Inc.

ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma.

View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-participate-in-two-upcoming-investor-conferences-301673393.html

SOURCE ESSA Pharma Inc

FAQ

What investor conferences will ESSA Pharma (EPIX) participate in?

ESSA Pharma will participate in the Jefferies London Healthcare Conference on November 17, 2022, and the Piper Sandler 34th Annual Healthcare Conference on November 29, 2022.

Who will represent ESSA Pharma at the upcoming investor conferences?

David R. Parkinson (CEO), Peter Virsik (COO), and David S. Wood (CFO) will represent ESSA Pharma in one-on-one meetings.

What is the format of the presentations at the conferences for ESSA Pharma (EPIX)?

The presentations will be conducted as fireside chats at both the Jefferies and Piper Sandler conferences.

How can I access the live webcast of ESSA Pharma's presentation?

The live webcast of the Jefferies fireside chat can be accessed via the Investors section of ESSA Pharma's website.

When will the webcast of ESSA Pharma's presentation be available for replay?

The webcast will be archived on ESSA Pharma's website for 90 days after the event.